 | • レポートコード：360iR22DE172 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、246ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に3,048.70百万ドルであった世界のデジタルセラピューティクス市場規模が、2022年に3,766.53百万ドルになり、2027年まで年平均23.72％で成長して10,934.75百万ドルに達すると予測しています。本レポートでは、デジタルセラピューティクスの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、疾患別（循環器疾患、中枢神経系疾患、慢性呼吸器疾患、糖尿病、肥満）分析、コンポーネント別（機器、ソフトウェア）分析、流通別（B2B、B2C）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。本書では、2morrow Inc.、Akili Interactive Labs、Ayogo Health Inc.、Better Therapeutics、BigHealth、Canary Health Inc.、Click Therapeutics、Cognoa、Ginger.Io, Inc.、Happify、Kaia Health、Lark Technologies、Livongo Health, Inc.、Mango Health Inc.、Mindstrong Health、Noom Inc.などの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のデジタルセラピューティクス市場規模：疾患別 - 循環器疾患における市場規模 - 中枢神経系疾患における市場規模 - 慢性呼吸器疾患における市場規模 - 糖尿病における市場規模 - 肥満における市場規模 ・世界のデジタルセラピューティクス市場規模：コンポーネント別 - 機器の市場規模 - プソフトウェアの市場規模 ・世界のデジタルセラピューティクス市場規模：流通別 - B2Bチャネルの市場規模 - B2Cチャネルの市場規模 ・世界のデジタルセラピューティクス市場規模：地域別 - 南北アメリカのデジタルセラピューティクス市場規模 アメリカのデジタルセラピューティクス市場規模 カナダのデジタルセラピューティクス市場規模 ブラジルのデジタルセラピューティクス市場規模 ... - アジア太平洋のデジタルセラピューティクス市場規模 日本のデジタルセラピューティクス市場規模 中国のデジタルセラピューティクス市場規模 インドのデジタルセラピューティクス市場規模 韓国のデジタルセラピューティクス市場規模 台湾のデジタルセラピューティクス市場規模 ... -ヨーロッパ/中東/アフリカのデジタルセラピューティクス市場規模 イギリスのデジタルセラピューティクス市場規模 ドイツのデジタルセラピューティクス市場規模 フランスのデジタルセラピューティクス市場規模 ロシアのデジタルセラピューティクス市場規模 ... -その他地域のデジタルセラピューティクス市場規模 ・競争状況 ・企業情報 |
The Global Digital Therapeutics Market size was estimated at USD 3,048.70 million in 2021 and expected to reach USD 3,766.53 million in 2022, and is projected to grow at a CAGR 23.72% to reach USD 10,934.75 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Digital Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Indication, the market was studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation.
Based on Component, the market was studied across Devices and Software.
Based on Distribution, the market was studied across B2B and B2C. The B2B is further studied across Employer, Payer, Pharmaceutical Company, and Provider. The B2C is further studied across Caregiver and Patient.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Digital Therapeutics market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Digital Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Digital Therapeutics Market, including 2morrow Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, BigHealth, Canary Health Inc., Click Therapeutics, Cognoa, Ginger.Io, Inc., Happify, Kaia Health, Lark Technologies, Livongo Health, Inc., Mango Health Inc., Mindstrong Health, Noom Inc., Omada Health, Inc., One Drop, Pear Therapeutics, Propeller Health, Proteus Digital Health, Inc., Twine health, Inc., Vitra Health, Welldoc, Inc., and Wellthy Therapeutics.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Digital Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Digital Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Digital Therapeutics Market?
6. What is the market share of the leading vendors in the Global Digital Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Digital Therapeutics Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of preventive chronic diseases
5.1.1.2. Control on healthcare cost with focus on preventive healthcare
5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
5.1.2. Restraints
5.1.2.1. Limited awareness regarding digital therapeutics in the develping economies
5.1.3. Opportunities
5.1.3.1. Huge undiagnosed and untreated population base
5.1.3.2. Technology to undiscover the therapeutic areas
5.1.4. Challenges
5.1.4.1. Data privacy and security concerns
5.2. Cumulative Impact of COVID-19
6. Digital Therapeutics Market, by Indication
6.1. Introduction
6.2. Cardiovascular Disease
6.3. Central Nervous System Disorder
6.4. Chronic Respiratory Disease
6.5. Diabetes
6.6. Medication Adherence
6.7. Musculoskeletal Disorder
6.8. Obesity
6.9. Prediabetes
6.10. Smoking Cessation
7. Digital Therapeutics Market, by Component
7.1. Introduction
7.2. Devices
7.3. Software
8. Digital Therapeutics Market, by Distribution
8.1. Introduction
8.2. B2B
8.3.1. Employer
8.3.2. Payer
8.3.3. Pharmaceutical Company
8.3.4. Provider
8.3. B2C
8.4.1. Caregiver
8.4.2. Patient
9. Americas Digital Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Digital Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Digital Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 2morrow Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Akili Interactive Labs
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Ayogo Health Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Better Therapeutics
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. BigHealth
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Canary Health Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Click Therapeutics
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Cognoa
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Ginger.Io, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Happify
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Kaia Health
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Lark Technologies
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Livongo Health, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Mango Health Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Mindstrong Health
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Noom Inc.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Omada Health, Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. One Drop
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Pear Therapeutics
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Propeller Health
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Proteus Digital Health, Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Twine health, Inc.
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Vitra Health
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Welldoc, Inc.
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Wellthy Therapeutics
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing